NEWS
- What is SNAC in oral semaglutide?
- Advances in Macrocyclic Peptide Drug Development
- Nanovaccines: Current Advances and Challenges
- Monodispersed PEGs for Your ADC & PROTAC Development
- Insights into Ophthalmic Drug Innovations and Market Trends
- Antibody–Drug Conjugates Targeting MUC1
- Lumisight (pegulicianine) Gains FDA Approval to Detect Residual Cancer
- Emerging drugs for the treatment of PNH
- Aptamer Therapeutics: Current Status
- FDA Approves First NASH Drug & Other Pipelines in Clinical Trials